Skip to main navigation Skip to search Skip to main content

An exploration of the barriers and enablers to the initiation of clozapine in the community: a qualitative study using the Theoretical Domains Framework

  • Heather Kelly
  • , Gazala Akram
  • , Marianne Van-De-L'Isle
  • , Amanda McLean
  • , Chris Miller

Research output: Contribution to journal › Conference abstract › peer-review

Abstract

Introduction: Clozapine is the only antipsychotic licensed for treatment resistant schizophrenia (TRS) but requires slow titration and intensive physical health monitoring. Historically, clozapine initiation has largely occurred in hospital but it can also be successfully initiated in the community setting.

An NHS Lothian audit of patients whose clozapine treatment was planned whilst an outpatient found only 17.5% (n=7) to be subsequently initiated in the community. This is low in comparison to other studies which report successful community initiation of up to 86%. It is imperative that access to this gold standard treatment for TRS is expanded due to its benefits for both patients and the NHS in potentially avoiding hospital admission.

Aims and Objectives: To apply the Theoretical Domains Framework (TDF)3 to understand the barriers and enablers experienced by healthcare professionals in initiating clozapine in the community and to make recommendations to increase uptake of this process.

Method/Design: Semi-structured interviews were conducted with psychiatrists and Community Psychiatric Nurses from five Community Mental Health Teams and Intensive Home Treatment Teams in NHS Lothian. Interview schedules were designed based on the 14 domains of the TDF which were used as a ‘coding framework’ to undertake a thematic analysis of the interview data. Themes determined to be barriers or enablers were identified within predominant TDF domains and linked to evidence-based behaviour change interventions as suggested by the Behaviour Change Wheel.

This study evaluates a service currently provided by the NHS therefore NHS Research and Ethics approval has not been sought.

Results: Eight interviews were conducted to data saturation. Eleven themes demonstrating barriers and enablers to the community initiation of clozapine were identified across five predominant TDF domains. Barriers cited were: high demand on resources, inadequate guidance, interface issues between teams including a lack of definitive allocation of responsibility and perceived lack of confidence in participants’ ability to manage adverse events. Enablers identified included: agreement that clozapine initiation in the community was appropriate and preferable for some patients. Participants also described good team working within individual teams.

Discussion: Some barriers identified are previously known contributory factors to the general under-utilisation of clozapine, such as high demand on resources and lack of confidence. This study also identifies new findings specific to the initiation of clozapine in the community setting.

Most barriers described were attributed to organisational factors within the domain of Environmental Context and Resources therefore environmental restructuring, such as development of clearer local guidance, increased staffing or reduction of conflicting workload may be logical targets for intervention.

Social/Professional Role and Identity was cited as another prominent TDF domain and included barriers related to the interface between community teams therefore explicit accountability procedures should be considered. This aspect has not been described before and represents new findings.

Education and persuasive interventions may prove to be useful to improve clinicians’ confidence to manage adverse effects.

Conclusions: The study provides new insights into the barriers and enablers to the community initiation of clozapine, which are needed to improve access to clozapine for patients with TRS across various settings.
Original languageEnglish
Pages (from-to)6
Number of pages6
JournalJournal of Psychopharmacology
Volume35
Issue number1_suppl
DOIs
Publication statusPublished - 3 Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • clozapine
  • community use
  • antipsychotic
  • schizophrenia
  • Theoretical Domains Framework

Fingerprint

Dive into the research topics of 'An exploration of the barriers and enablers to the initiation of clozapine in the community: a qualitative study using the Theoretical Domains Framework'. Together they form a unique fingerprint.

Cite this